A research team from the Stony Brook Cancer Center found a novel therapeutic that is shown to be highly effective in reducing non-small cell lung cancer tumors.
A paper written by Hyungjin Kim, a professor in the Renaissance School of Medicine Department of Pharmacological Sciences, has been awarded the Carafoli Medal.
Stony Brook students, faculty and community members gathered at the SAC Plaza April 25 as SBU's American Cancer Society chapter hosted a Relay for Life event.
Agnieszka Bialkowska's cancer research at Stony Brook's Renaissance School of Medicine sits at the intersection of fundamental biology and therapeutic possibility.
Wei Zhao has spent more than two decades at Stony Brook University advancing technologies that stand to reshape how breast cancer is detected and diagnosed. A professor of radiology and vice chair for research, she has...
At a recent biomedical engineering seminar held at Stony Brook, Alex Xu spoke about finding biomarkers that can reveal a patient’s risk or treatment outcome.
Stony Brook University MBA candidate Anthony Pecorella, a punter on the football team, learned lessons from helping others in his own fight against cancer.
Stony Brook University signs licensing agreement with Perspective Therapeutics Image-guided radionuclide therapy uses radioactive molecules designed to specifically target and kill cancer cells while sparing non...
Kesem at Stony Brook University hosts free, fun-filled programs that offer a supportive and nurturing community for children affected by parental cancer.
Gliomas are incurable brain tumors. Researchers are trying to unlock the mysteries of how they originate from normal cells, which may lead to better treatments. A new study published in the journal Cell centers on...
There were an estimated 18 million cancer cases around the world in 2020. Though treatment methods have improved greatly in recent years, there is still a long way to go in combatting many types of cancer. “Right now we...
The findings of a study led by Stony Brook University Cancer Center may serve as a guide to design clinical trials for clinicians to optimize anesthesia choice for breast cancer surgery.
A Stony Brook-led team of researchers has identified a gene that could offer new hope for treating triple-negative breast cancer, the most aggressive subtype of the disease. Led by Lori Chan, PhD, Assistant Professor in...